Clover Health Investments, Corp. /De (CLOV) Stock Forecast Oct. 13, 2026
Analysis updated on Oct. 13, 2026 (UTC) · Alpha · vs marketSwitch to Total · Nasdaq
Clover Health Investments, Corp. /De (CLOV) stock forecast summary
Our AI ranks Clover Health Investments, Corp. /De outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
Clover Health Investments, Corp. /De is a mid-cap company with a market capitalization of $2.55B. It ranks number 8 by market capitalization among the 10 Hospital & Medical Service Plans issuers in our coverage with a current forecast. Its P/B Ratio of 6.79x is the highest of the 10 peers that report one. Its D/E Ratio of 0.91x is the lowest of the 10 peers that report one.
A per-ticker accuracy statistic for CLOV is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.3%, buy ≥ +0.5%, sell < -0.5%, strong sell < -1.6% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-13 signals)
A free account shows the exact forecast, rating and rank of 3 tickers you follow, CLOV included.
Follow CLOV freeCLOV price chart and AI forecast
How CLOV ranks among 5379 stocks
90D Alpha forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).
Clover Health Investments, Corp. /De (CLOV) fundamentals
Trailing twelve months. The industry median and the rank (1 = highest) are taken over the Hospital & Medical Service Plans peers listed below that report each metric.
Reported net income does not reconcile with earnings per share and the share count, so net-income-based ratios are withheld.
Valuation & Market
| Metric | CLOV | Rank |
|---|---|---|
| Market Cap | $2.55B | 8/10 |
| P/B Ratio | 6.79x | 1/10 |
| EPS | $-0.10 | – |
| Book Value/Share | $0.71 | – |
| Revenue/Share | $4.66 | – |
| FCF/Share | $0.14 | – |
Profitability & Margins
| Metric | CLOV | Rank |
|---|---|---|
| ROIC | -4.6% | 9/10 |
| Operating Margin | -0.7% | 9/10 |
| EBT Margin | -0.8% | 9/10 |
Financial Health
| Metric | CLOV | Rank |
|---|---|---|
| Current Ratio | 1.50x | 6/10 |
| D/E Ratio | 0.91x | 10/10 |
| Financial Leverage | 1.91x | 10/10 |
| Interest Coverage | -4115.3x | 9/9 |
| Working Capital | $162M | 8/10 |
Cash Flow
| Metric | CLOV | Rank |
|---|---|---|
| Operating Cash Flow | $77M | 10/10 |
| Free Cash Flow | $74M | 9/9 |
| Capital Spending | -$3M | 1/9 |
| FCF/Sales | 3.0% | 7/9 |
| CapEx/Sales | 0.1% | 9/9 |
Operational Efficiency
| Metric | CLOV | Rank |
|---|---|---|
| Asset Turnover | 3.44x | 2/10 |
| Fixed Assets Turnover | 342.5x | 1/10 |
Income Statement
| Metric | CLOV | Rank |
|---|---|---|
| Total Revenue | $2.48B | 9/10 |
| Operating Income | -$18M | 9/10 |
Dividend & Shareholder Information
| Metric | CLOV | Rank |
|---|---|---|
| Shares Outstanding | 531M | – |
Balance Sheet Highlights (USD millions)
| Total Current Assets | $485M | 67.4% of assets |
| Cash & Short-term Investments | $199M | 27.6% of assets |
| Total Liabilities | $344M | 47.8% of assets |
CLOV quarterly financials and insider trading
Clover Health Investments, Corp. /De (CLOV) industry peers
Companies classified under the same SEC industry code as Clover Health Investments, Corp. /De (Hospital & Medical Service Plans): 10 common-stock issuers with a forecast this week, one row per issuer, largest first. This is a classification match, not a curated list of competitors.
Reveal all forecasts · See exact % predictions for all competitors
Sign up free| Company | 90-Day AI Forecast (Alpha) | Market Cap |
|---|---|---|
| CLOV Clover Health Investments, Corp. /De | ▲ | $2.55B |
| UNH Unitedhealth Group Inc | ▲ | $339.76B |
| ELV Elevance Health, Inc. | ▲ | $92.23B |
| CI Cigna Group | ▲ | $74.66B |
| HUM Humana Inc | ▲ | $50.47B |
| CNC Centene Corp | ▲ | $34.02B |
| MOH Molina Healthcare, Inc. | ▲ | $10.94B |
| OSCR Oscar Health, Inc. | ▲ | $10.43B |
| ALHC Alignment Healthcare, Inc. | ▲ | $1.72B |
| TRUP Trupanion, Inc. | ▼ | $1.15B |
Where CLOV sits on the market map
Clover Health Investments, Corp. /De (CLOV) stock news
Loading...
Clover Health Investments, Corp. /De (CLOV) stock forecast FAQ
What is the Clover Health Investments, Corp. /De (CLOV) stock forecast?
Our AI ranks Clover Health Investments, Corp. /De outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.
How accurate are Clover Health Investments, Corp. /De stock predictions?
A per-ticker accuracy statistic for CLOV is published only once its sample size is known. Across our coverage, the out-of-sample test on 4537 stocks from 2025-01-06 to 2026-06-09 produced a positive net return in 73.7% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report
How often are Clover Health Investments, Corp. /De forecasts updated?
Clover Health Investments, Corp. /De forecasts are refreshed on trading days as the daily model run completes. The forecast on this page was produced on Oct. 13, 2026.
Which companies are Clover Health Investments, Corp. /De's industry peers?
10 issuers in our coverage, CLOV included, share the SEC industry code Hospital & Medical Service Plans. The largest are: Unitedhealth Group Inc (UNH), Elevance Health, Inc. (ELV), Cigna Group (CI), Humana Inc (HUM), Centene Corp (CNC), Molina Healthcare, Inc. (MOH).
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.